Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Monday, November 23, 2020

Identification of Genetic Determinants for Treatment Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for HER2 Positive Breast Cancer

Cancer shared this article with you from Inoreader
Condition:   HER2-positive Breast Cancer Intervention:   Other: Blood sample for genetic analysis Sponsor:   Institut de cancérologie Strasbourg Europe Not yet recruiting (Source: ClinicalTrials.gov)
View on the web

No comments:

Post a Comment